Cipla informs about press release

12 Aug 2021 Evaluate

Cipla has informed that it enclosed press release dated 12th August 2021, titled ‘Cipla receives final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05%’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1357.80 12.10 (0.90%)
26-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1784.60
Dr. Reddys Lab 1318.90
Cipla 1357.80
Zydus Lifesciences 938.15
Lupin 2323.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×